Pragmatic classification of superficial neoplastic colorectal lesions.

PubWeight™: 1.02‹?› | Rank: Top 15%

🔗 View Article (PMID 19879563)

Published in Gastrointest Endosc on October 31, 2009

Authors

René Lambert1, Shin Ei Kudo, Michael Vieth, John I Allen, Hiroaki Fujii, Takahiro Fujii, Hiroshi Kashida, Takahisa Matsuda, Masaki Mori, Hiroshi Saito, Tadakazu Shimoda, Shinji Tanaka, Hidenobu Watanabe, Joseph J Sung, Andrew D Feld, John M Inadomi, Michael J O'Brien, David A Lieberman, David F Ransohoff, Roy M Soetikno, Ann Zauber, Claudio Rolim Teixeira, Jean Francois Rey, Edgar Jaramillo, Carlos A Rubio, Andre Van Gossum, Michael Jung, Jeremy R Jass, George Triadafilopoulos

Author Affiliations

1: Screening Group, International Agency for Research on Cancer, Lyon, France.

Articles citing this

Cancer risk in IBD: how to diagnose and how to manage DALM and ALM. World J Gastroenterol (2011) 1.23

Sessile serrated adenomas: demographic, endoscopic and pathological characteristics. World J Gastroenterol (2010) 1.03

Risk factors for serrated polyps of the colorectum. Dig Dis Sci (2014) 0.96

Preinvasive colorectal lesion transcriptomes correlate with endoscopic morphology (polypoid vs. nonpolypoid). EMBO Mol Med (2011) 0.93

Early rectal cancer: the European Association for Endoscopic Surgery (EAES) clinical consensus conference. Surg Endosc (2015) 0.93

Endoscopic submucosal dissection specimens in early colorectal cancer: lateral margins, macroscopic techniques, and possible pitfalls. Virchows Arch (2016) 0.89

Endoscopy in screening for digestive cancer. World J Gastrointest Endosc (2012) 0.89

Practice parameters for early colon cancer management: Italian Society of Colorectal Surgery (Società Italiana di Chirurgia Colo-Rettale; SICCR) guidelines. Tech Coloproctol (2015) 0.82

Non-polypoid colorectal neoplasms: Classification, therapy and follow-up. World J Gastroenterol (2015) 0.81

Clinicopathological characteristics of laterally spreading colorectal tumor. PLoS One (2014) 0.80

Prevention of gastrointestinal cancer by surveillance endoscopy. EPMA J (2010) 0.78

New paradigms for colonoscopic management of diminutive colorectal polyps: predict, resect, and discard or do not resect? Clin Endosc (2013) 0.78

Performance measures for lower gastrointestinal endoscopy: a European Society of Gastrointestinal Endoscopy (ESGE) quality improvement initiative. United European Gastroenterol J (2017) 0.78

Histological Distinction between the Granular and Nongranular Types of Laterally Spreading Tumors of the Colorectum. Gastroenterol Res Pract (2014) 0.75

Characteristics of colorectal tumours in asymptomatic patients with negative immunochemical faecal occult blood test results. Mol Clin Oncol (2015) 0.75

The clinical impact of serrated colorectal polyps. Clin Epidemiol (2017) 0.75

The Serrated Polyp Pathway: Is It Time to Alter Surveillance Guidelines? Curr Gastroenterol Rep (2017) 0.75

Articles by these authors

Gefitinib versus cisplatin plus docetaxel in patients with non-small-cell lung cancer harbouring mutations of the epidermal growth factor receptor (WJTOG3405): an open label, randomised phase 3 trial. Lancet Oncol (2009) 21.94

Genome-wide meta-analysis increases to 71 the number of confirmed Crohn's disease susceptibility loci. Nat Genet (2010) 17.38

Colonoscopic polypectomy and long-term prevention of colorectal-cancer deaths. N Engl J Med (2012) 16.55

Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: a joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology. Gastroenterology (2008) 15.86

Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: a joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology. CA Cancer J Clin (2008) 12.90

Cardiovascular risk associated with celecoxib in a clinical trial for colorectal adenoma prevention. N Engl J Med (2005) 12.46

American College of Gastroenterology guidelines for colorectal cancer screening 2009 [corrected]. Am J Gastroenterol (2009) 12.16

Multitarget stool DNA testing for colorectal-cancer screening. N Engl J Med (2014) 11.07

Abscisic acid inhibits type 2C protein phosphatases via the PYR/PYL family of START proteins. Science (2009) 10.21

A randomized trial of aspirin to prevent colorectal adenomas. N Engl J Med (2003) 9.18

Incidence of lymph node metastasis from early gastric cancer: estimation with a large number of cases at two large centers. Gastric Cancer (2000) 8.85

Folic acid for the prevention of colorectal adenomas: a randomized clinical trial. JAMA (2007) 7.93

Quality in the technical performance of colonoscopy and the continuous quality improvement process for colonoscopy: recommendations of the U.S. Multi-Society Task Force on Colorectal Cancer. Am J Gastroenterol (2002) 6.63

Confocal laser endoscopy for diagnosing intraepithelial neoplasias and colorectal cancer in vivo. Gastroenterology (2004) 6.60

Fecal DNA versus fecal occult blood for colorectal-cancer screening in an average-risk population. N Engl J Med (2004) 6.42

Long noncoding RNA HOTAIR regulates polycomb-dependent chromatin modification and is associated with poor prognosis in colorectal cancers. Cancer Res (2011) 6.02

American Gastroenterological Association medical position statement on the management of Barrett's esophagus. Gastroenterology (2011) 5.93

Immunohistochemistry versus microsatellite instability testing in phenotyping colorectal tumors. J Clin Oncol (2002) 5.91

Bone-density testing interval and transition to osteoporosis in older women. N Engl J Med (2012) 5.81

Prevalence of Barrett's esophagus in the general population: an endoscopic study. Gastroenterology (2005) 5.77

Advantage of endoscopic submucosal dissection compared with EMR for early gastric cancer. Gastrointest Endosc (2006) 5.42

Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2010 for the treatment of colorectal cancer. Int J Clin Oncol (2011) 5.39

Fluorouracil versus combination of irinotecan plus cisplatin versus S-1 in metastatic gastric cancer: a randomised phase 3 study. Lancet Oncol (2009) 5.19

Methylene blue-aided chromoendoscopy for the detection of intraepithelial neoplasia and colon cancer in ulcerative colitis. Gastroenterology (2003) 5.11

Endoscopic submucosal dissection of early gastric cancer. J Gastroenterol (2006) 4.90

Guidelines for colonoscopy surveillance after polypectomy: a consensus update by the US Multi-Society Task Force on Colorectal Cancer and the American Cancer Society. Gastroenterology (2006) 4.57

Five-year risk of colorectal neoplasia after negative screening colonoscopy. N Engl J Med (2008) 4.55

Are physicians doing too much colonoscopy? A national survey of colorectal surveillance after polypectomy. Ann Intern Med (2004) 4.49

Clinical significance of circulating tumor cells, including cancer stem-like cells, in peripheral blood for recurrence and prognosis in patients with Dukes' stage B and C colorectal cancer. J Clin Oncol (2011) 4.48

Accuracy of screening for fecal occult blood on a single stool sample obtained by digital rectal examination: a comparison with recommended sampling practice. Ann Intern Med (2005) 4.38

Curative endoscopic resection of early esophageal adenocarcinomas (Barrett's cancer). Gastrointest Endosc (2007) 4.28

Serrated lesions of the colorectum: review and recommendations from an expert panel. Am J Gastroenterol (2012) 4.22

Chromoscopy-guided endomicroscopy increases the diagnostic yield of intraepithelial neoplasia in ulcerative colitis. Gastroenterology (2007) 4.09

A national study of cardiopulmonary unplanned events after GI endoscopy. Gastrointest Endosc (2007) 4.09

Incidence of lymph node metastasis and the feasibility of endoscopic resection for undifferentiated-type early gastric cancer. Gastric Cancer (2009) 4.04

Reprogramming of mouse and human cells to pluripotency using mature microRNAs. Cell Stem Cell (2011) 4.02

Risk factors for drug-resistant pathogens in community-acquired and healthcare-associated pneumonia. Am J Respir Crit Care Med (2013) 3.95

The development and validation of an endoscopic grading system for Barrett's esophagus: the Prague C & M criteria. Gastroenterology (2006) 3.80

Screening for colorectal neoplasms with new fecal occult blood tests: update on performance characteristics. J Natl Cancer Inst (2007) 3.80

Effect of aspirin or resistant starch on colorectal neoplasia in the Lynch syndrome. N Engl J Med (2008) 3.76

Five-year colon surveillance after screening colonoscopy. Gastroenterology (2007) 3.74

In vivo histology of Barrett's esophagus and associated neoplasia by confocal laser endomicroscopy. Clin Gastroenterol Hepatol (2006) 3.69

Characterization of a side population of cancer cells from human gastrointestinal system. Stem Cells (2005) 3.66

Early detection of superficial squamous cell carcinoma in the head and neck region and esophagus by narrow band imaging: a multicenter randomized controlled trial. J Clin Oncol (2010) 3.64

A gate-latch-lock mechanism for hormone signalling by abscisic acid receptors. Nature (2009) 3.63

CD13 is a therapeutic target in human liver cancer stem cells. J Clin Invest (2010) 3.60

Prediction of progression of coronary artery disease and clinical outcomes using vascular profiling of endothelial shear stress and arterial plaque characteristics: the PREDICTION Study. Circulation (2012) 3.53

A prospective, multicenter study of 1111 colorectal endoscopic submucosal dissections (with video). Gastrointest Endosc (2010) 3.53

Derivation and Validation of a Scoring System to Stratify Risk for Advanced Colorectal Neoplasia in Asymptomatic Adults: A Cross-sectional Study. Ann Intern Med (2015) 3.45

miR-124 and miR-203 are epigenetically silenced tumor-suppressive microRNAs in hepatocellular carcinoma. Carcinogenesis (2009) 3.45

Local endoscopic therapy for intraepithelial high-grade neoplasia and early adenocarcinoma in Barrett's oesophagus: acute-phase and intermediate results of a new treatment approach. Eur J Gastroenterol Hepatol (2002) 3.41

Using risk for advanced proximal colonic neoplasia to tailor endoscopic screening for colorectal cancer. Ann Intern Med (2003) 3.39

Epithelial-mesenchymal transition in cancer development and its clinical significance. Cancer Sci (2009) 3.39

Familial cancer associated with a polymorphism in ARLTS1. N Engl J Med (2005) 3.35

Adverse events after outpatient colonoscopy in the Medicare population. Ann Intern Med (2009) 3.34

Serrated polyps of the large intestine: a morphologic and molecular review of an evolving concept. Am J Clin Pathol (2005) 3.29

Cardiac rather than intestinal-type background in endoscopic resection specimens of minute Barrett adenocarcinoma. Hum Pathol (2008) 3.27

Prevalence of Barrett's esophagus in asymptomatic individuals. Gastroenterology (2002) 3.26

High prevalence of sessile serrated adenomas with BRAF mutations: a prospective study of patients undergoing colonoscopy. Gastroenterology (2006) 3.24

Guidelines for colonoscopy surveillance after polypectomy: a consensus update by the US Multi-Society Task Force on Colorectal Cancer and the American Cancer Society. CA Cancer J Clin (2006) 3.21

Use of molecular tumor characteristics to prioritize mismatch repair gene testing in early-onset colorectal cancer. J Clin Oncol (2005) 3.19

Procedural success and complications of large-scale screening colonoscopy. Gastrointest Endosc (2002) 3.16

Circumferential ablation of Barrett's esophagus that contains high-grade dysplasia: a U.S. Multicenter Registry. Gastrointest Endosc (2008) 3.13

Pharmacologic unmasking of epigenetically silenced tumor suppressor genes in esophageal squamous cell carcinoma. Cancer Cell (2002) 3.12

Results of screening colonoscopy among persons 40 to 49 years of age. N Engl J Med (2002) 3.11

Gastroesophageal reflux, barrett esophagus, and esophageal cancer: scientific review. JAMA (2002) 3.11

A framework for evaluating biomarkers for early detection: validation of biomarker panels for ovarian cancer. Cancer Prev Res (Phila) (2011) 3.03

A national survey of primary care physicians' methods for screening for fecal occult blood. Ann Intern Med (2005) 3.01

Survival benefit of bursectomy in patients with resectable gastric cancer: interim analysis results of a randomized controlled trial. Gastric Cancer (2011) 2.97

Randomized phase III trial of fluorouracil alone versus fluorouracil plus cisplatin versus uracil and tegafur plus mitomycin in patients with unresectable, advanced gastric cancer: The Japan Clinical Oncology Group Study (JCOG9205). J Clin Oncol (2003) 2.97

Adequacy of reporting race/ethnicity in clinical trials in areas of health disparities. J Clin Epidemiol (2003) 2.94

Risk factors for complications after performance of ERCP. Gastrointest Endosc (2002) 2.93

The Scientific Foundation for personal genomics: recommendations from a National Institutes of Health-Centers for Disease Control and Prevention multidisciplinary workshop. Genet Med (2009) 2.91

Genetic variation in PSCA is associated with susceptibility to diffuse-type gastric cancer. Nat Genet (2008) 2.89

Correlations between lymph node metastasis and depth of submucosal invasion in submucosal invasive colorectal carcinoma: a Japanese collaborative study. J Gastroenterol (2004) 2.88

Celecoxib versus naproxen and diclofenac in osteoarthritis patients: SUCCESS-I Study. Am J Med (2006) 2.87

Risk of perforation from a colonoscopy in adults: a large population-based study. Gastrointest Endosc (2009) 2.78

Endoscopic treatment of large superficial colorectal tumors: a case series of 200 endoscopic submucosal dissections (with video). Gastrointest Endosc (2007) 2.77

International variation in screening mammography interpretations in community-based programs. J Natl Cancer Inst (2003) 2.75

Transparent Reporting of a multivariable prediction model for Individual Prognosis or Diagnosis (TRIPOD): explanation and elaboration. Ann Intern Med (2015) 2.71

Reports of "satisfactory relief" by IBS patients receiving usual medical care are confounded by baseline symptom severity and do not accurately reflect symptom improvement. Am J Gastroenterol (2006) 2.71

One-year risk for advanced colorectal neoplasia: U.S. versus U.K. risk-stratification guidelines. Ann Intern Med (2012) 2.70

Japanese Society for Cancer of the Colon and Rectum (JSCCR) Guidelines 2014 for treatment of colorectal cancer. Int J Clin Oncol (2015) 2.70

Consensus statements for management of Barrett's dysplasia and early-stage esophageal adenocarcinoma, based on a Delphi process. Gastroenterology (2012) 2.68

CCAT2, a novel noncoding RNA mapping to 8q24, underlies metastatic progression and chromosomal instability in colon cancer. Genome Res (2013) 2.57

Transforming epidemiology for 21st century medicine and public health. Cancer Epidemiol Biomarkers Prev (2013) 2.56

The Japanese guidelines for gastric cancer screening. Jpn J Clin Oncol (2008) 2.56

A pooled analysis of advanced colorectal neoplasia diagnoses after colonoscopic polypectomy. Gastroenterology (2008) 2.56

Cholesterol glucosylation promotes immune evasion by Helicobacter pylori. Nat Med (2006) 2.53

Effectiveness of glycerol as a submucosal injection for EMR. Gastrointest Endosc (2005) 2.52

The American Society for Gastrointestinal Endoscopy PIVI (Preservation and Incorporation of Valuable Endoscopic Innovations) on real-time endoscopic assessment of the histology of diminutive colorectal polyps. Gastrointest Endosc (2011) 2.51

American Gastroenterological Association technical review on the management of Barrett's esophagus. Gastroenterology (2011) 2.50

Colorectal cancers soon after colonoscopy: a pooled multicohort analysis. Gut (2013) 2.50

Clinical outcome of endoscopic submucosal dissection versus endoscopic mucosal resection of large colorectal tumors as determined by curative resection. Surg Endosc (2009) 2.48